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Abstract
Background: Lower limb paralysis occurs in 11% of patients after surgical procedure of thoracic
or thoracoabdominal aneurysms and is an unpredictable and distressful complication. The aim of
this study was to investigate the effects of tetramethylpyrazine (TMP), an intravenous drug made
from traditional Chinese herbs, on the neurologic outcome and hisotpathology after transient
spinal cord ischemia in rabbits.
Methods: Forty-five male New Zealand white rabbits were anesthetized with isoflurane and spinal
cord ischemia was induced for 20 min by infrarenal aortic occlusion. Animals were randomly
allocated to one of five groups (n = 8 each). Group C received no pharmacologic intervention.
Group P received intravenous infusion of 30 mg·kg-1 TMP within 30 min before aortic occlusion.
Group T1, Group T2 and Group T3 received intravenous infusion of 15, 30 and 60 mg·kg-1 TMP
respectively within 30 min after reperfusion. In the sham group (n = 5), the animals underwent the
same procedures as the control group except infrarental aortic unocclusion. Neurologic status was
scored by using the Tarlov criteria (in which 4 is normal and 0 is paraplegia) at 4 h, 8 h, 12 h, 24 h,
and 48 h after reperfusion. All animals were sacrificed at 48 h after reperfusion and the spinal cords
(L5) were removed immediately for histopathologic study.
Results: All animals in the control group became paraplegic. Neurologic status and histopathology
(48 h) in the Groups P, T2 and T3 were significantly better than those in the control group (P <
0.05). There was a strong correlation between the final neurologic scores and the number of
normal neurons in the anterior spinal cord (r = 0.776, P < 0.01).
Conclusion: Tetramethylpyrazine significantly reduces neurologic injury related to spinal cord
ischemia and reperfusion after aortic occlusion within a certain range of dose.
Background
Spinal cord ischemic injury remains a devastating and un-
predictable complication, which develops paralysis or
paraplegia in proximately 11~40% of patients undergoing
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descending thoracic or thoracoabdominal aneurysm re-
pair [1,2]. Therefore, a great number of efforts have been
focused on solving this problem, which include surgical
techniques, pharmacologic intervention and mechanical
methods, used such as hypothermia, cerebrospinal fluid
drainage, and retrograde venous perfusion [3–6]. The cel-
lular and molecular mechanisms of ischemic spinal cord
injury are not fully understood. But multiple studies have
suggested that calcium overload, free radical production,
platelet aggregation, neutrophil accumulation and adhe-
sion following ischemia may contribute to neuronal
ischemic spinal cord injury [4,8]. Pharmacologic studies
have demonstrated tetramethylpyrazine (TMP), an intra-
venous drug made from traditional Chinese herbs, was
able to inhibit release of intracellular calcium and to scav-
enge oxygen free radicals [9,10]. The significant efficacy of
TMP in cerebral ischemia and reperfusion injury was con-
firmed [11,12]. However, no study has been designed to
examine it's use in spinal cord ischemia. This study was
designed to investigate the protective efficacy and the
dose-response relationship of TMP against the neurologic
and histophathologic outcomes of spinal cord ischemia
and reperfusion injury relating to aortic occlusion in rab-
bits.
Materials and Methods
Experimental Groups
Forty-five male New Zealand White rabbits (provided by
Experimental Animal Center of the Fourth Military Medi-
cal University), weighing 1.8 to 2.6 kg, were randomly as-
signed to one of six groups (n = 8 each). In the control
group, the animals underwent infrarental aortic occlusion
and intravenous infusion of 0.9% sodium chloride (vol-
ume was identical to those of TMP infusion). In protec-
tion group (Group P), the animals received 30 mg·kg-1
TMP within 30 min before aortic occlusion. In treatment
groups T1, T2 and T3, the animals received 15,30 and 60
mg·kg-1 TMP respectively at the onset of reperfusion. In
the sham group (n = 5), the animals underwent the same
procedures as control group except infrarental aortic un-
occlusion. The TMP (Changzhou Pharmacological Co.,
China, NO: 990129), diluted in 10 ml of 0.9% sodium
chloride, was intravenously infused at a rate of 20 ml·h-1
by using microinjector (3 M, Model 600, USA).
Spinal Cord Ischemia
The spinal cord ischemia was induced based on the meth-
od previously described by Wakamatsu et al [5]. After an
overnight fast with unrestricted access to water, the rabbits
were induced in plastic box with 4% isoflurane in oxygen.
Animals were allowed to breath spontaneously. Anesthe-
sia was maintained by inhalation of 2%~3% isoflurane in
oxygen administered by face mask at a flow rate of
4l·min-1. The left ear vein was cannulated with a 24-gauge
catheter for the infusion of lactated Ringer's solution and
TMP, the right ear artery was cannulated with a 24-gauge
catheter for the measurement of proximal arterial blood
pressure and for drawing blood samples. The distal arteri-
al blood pressure was measured via a 24-gauge catheter in-
serted into the right femoral artery. With the rabbits in the
prone position, the abdomen was opened through a verti-
cal midline incision to expose the abdominal aorta. The
aorta and its branches were meticulously dissected from
caudal to the left renal artery. Heparin (150 U·kg-1) was
given and intravenously a circumaortic occlusion device
was placed across the aorta just distal to the left renal ar-
tery to occlude blood supply to the lumbar spinal cord.
Spinal cord ischemia was induced by pulling the device.
After a previously established ideal ischemic time of pre-
cisely 20 minutes, the device was removed, thus begin-
ning reperfusion. After completion of surgery, the aorta
was detected to be intact, and the abdominal wall was
closed with 4-0 nylon suture in separate layers. The local
infiltration around the wound with 0.25% bupivacaine
hydrochloride was applied for postoperative analgesia.
The animals were administered gentamicin (40,000 U)
i.m., and allowed to recover with free access to food and
water. During the procedure, lactated Ringer's solution
was infused via ear vein. Proximal and distal arterial
blood pressure and heart beat were continuously moni-
tored (Spacelab, model 90206A, USA), body temperature
was continuously monitored with a flexible probe (509
Monitor, USA) inserted 5 cm into the rectum and core
temperature was maintained at 38~39°C by heating
lamps. Arterial blood was sampled for determination of
blood gases (AVL-2, Switzerland) and plasma glucose
(One Touch II, USA) at 20 minutes before ischemia, 10
minutes after ischemia and 20 minutes after reperfusion
respectively.
Neurologic Assessment
At 4 h, 8 h, 12 h, 24 h, and 48 h after perfusion, the motor
function scores (MFS) were scaled in all rabbits by an ob-
server unaware of the treatment group using the modified
Tarlov criteria [13] as follows: 0: paraplegic with no lower
extremity function;1: poor lower extremity function, weak
antigravity movement only; 2: some lower extremity func-
tion with good antigravity strength but inability to draw
legs under body; 3: ability to draw under body and hop,
but not normally; 4: normal motor function.
Histophathologic examination
After completion of the MFS at 48 h, the animals were re-
anesthetized with 2% sodium pentobarbital, and tran-
scardial perfusion and fixation were performed with 1000
mL of heparinized saline followed by 500 mL 10% phos-
phate-buffered formalin. The spinal cord was removed
and refrigerated in 10% phosphate-buffered formalin for
48 h, then was embedded in paraffin. Coronal section of
the spinal cord (L5 level) was cut at the thickness of 6 µmBMC Neurology 2002, 2 http://www.biomedcentral.com/1471-2377/2/1
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and stained with hematoxylin and eosin. Neuronal injury
was evaluated at 200 ×  magnification by an observer una-
ware of the treatment group.
Statistical Analysis
Values are expressed as mean ± SD. The physiologic varia-
bles were analyzed with repeated measures analysis of var-
iance (ANOVA). The hindlimb motor function and the
number of normal neurons in the anterior spinal cord
were analyzed using a nonparametric method (Kruskal-
Wallis test) followed by the Mann-Whitney U-test with
Bonferroni correction. The correlation of hindlimb motor
function scores and the number of normal neurons in the
anterior spinal cord were analyzed using Spearman's rank
correlation. A P value < 0.05 was considered statistically
significant.
Results
Physiologic and hemodynamic parameters
Physiologic variables are shown in Table 1 (see additional
file 1) . Rectal temperature, heart rate, and mean arterial
blood pressure were not affected by the slow infusion of
TMP. There were no statistical differences in the physio-
logic parameters of the animals among the five groups.
PaO2, PaCO2 and arterial oxygen saturation were within
normal range in all animals.
Neurologic outcomes
The animals in the sham group had normal motor func-
tion during study. The MFS at 4 h, 8 h, 12 h, 24 h, and 48
h in the groups P, T2 and T3 received intervention of TMP
30 mg·kg-1(P), 30 mg·kg-1(T2), and 60 mg·kg-1 (T3) was
significantly better than that in the control group (P <
0.05). There was no significant difference in the MFS
among groups P, T2 and T3. At 48 h after reperfusion, all
rabbits in the control group showed paralysis of the hind
limbs with median Tarlov score of 0. Except for one rabbit
in group T2, all animals improved to scores of 3 or 4 in
groups P, T2 and T3 (Figure 1).
Histopathologic examination
Histopathology of the lumbar spinal cord (L5) was exam-
ined in all animals. The numbers of normal neurons in
the anterior spinal cord at 48 h after reperfusion of groups
P, T2, and T3 were significantly greater than that of control
group (P < 0.05). No difference was found among groups
P, T2 and T3 (Figure 2). The morphologic changes were
observed in rabbits with different MFS. Figure 3 shows
that light microphotographs of anterior horn of the spinal
cord from the rabbit in control group with paraplegia
(Tarlov grade 0), exhibited few normal neurons, and de-
struction of the motor neurons with karyolysis and vacu-
olization of anterior horn. No sign of neuronal damage
was observed in the spinal cord of rabbit in group T3 with
normal motor function (Tarlov score 4). Well-preserved,
normal-looking motor neurons were seen in figure 4. Fig-
ure 5 shows that cross-section of anterior horn of the spi-
nal cord from the rabbit rated Tarlov score 2 in group T1,
exhibited moderate motor neuronal degeneration with
shrunken and triangular shaped perikaryon.
Correlation between motor function scores and the num-
bers of normal neurons at anterior spinal cord
There was a strong correlation between the final neurolog-
ic outcome and the numbers of normal neurons in anteri-
or spinal cord 48 h after reperfusion (r = 0.776, P < 0.01).
Discussion
The present study demonstrated that TMP by intravenous
administration before or after aortic occlusion significant-
ly ameliorates transient spinal cord ischemia (20 min)
Figure 1
The neurologic outcomes 48 h after reperfusion
Figure 2
The umber of normal motor neurons in the anterior spinal
cord 48 h after reperfusionBMC Neurology 2002, 2 http://www.biomedcentral.com/1471-2377/2/1
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produced by occlusion of the infrarenal aorta in rabbits.
No obvious dose-response effect was observed within the
dose range studied in the present study.
Partial to complete paralysis during the early postopera-
tive period is an unfortunate and unpredictable conse-
quence of operation on the descending thoracic or
thoracoabdomina aorta or direct spinal cord surgery for
tumors. Neurologic deficits may be noted during the im-
mediate postoperative period or may be manifested many
hours after operation, which severely affluences surgical
outcome, and leads to massive psychological and finan-
cial burden. Multiple studies [3–6] have been done to ex-
amine the effects of various pharmacologic agents on
spinal cord ischemia, but no clinically effective treatments
have yet been developed. TMP, one of the alkaloids in li-
gusticum Wallichii Franch (L. Wallichill), an active ingre-
dient in Chuanxiong, has been widely used, especially in
the treatment of patients with cerebrovasular ischemic
diseases in China and manifested its therapeutic actions
in clinic [14,15]. TMP has been demonstrated to provide
significant protective properties against acute brain
ischemic injury induced by ligation of bilateral common
carotid arteries (2VO) in gerbils and cerebral infarction
produced by middle cerebral artery occlusion (MCAO) in
rats in experimental studies [11,12], but limited data exist
regarding the use of TMP in spinal cord injury. The rabbit
model of spinal cord ischemia used in this study, which
mimics aortic occlusion during operation on the thoraco-
abdominal aorta in clinic, is a reliable and reproducible
model for producing neurologic deficit and testing drugs
that might serve to protect the spinal cord from ischemic
injury [16].
There was significant improvement in the neurologic out-
comes of rabbits that received TMP comparing with the
control group. Both protective group and treated group
with the same dose of TMP had higher Tarlov scores than
that in the control animals. Animals treated with TMP be-
fore aortic occlusion had 100% recovery at 48 h. These an-
imals were able to stand without difficulty and hop
normally. Except for one rabbit treated with TMP at the
onset of reperfusion, other animals reached a median Tar-
lov score of 3 after 48 h with standing or hopping. In con-
trast, control animals showed paralysis of the hind limbs.
It was confirmed in present study that the motor function
scores at different time points and the number of normal
neurons in the anterior spinal cord at 48 h in the two
Figure 3
Cross-section of anterior horn spinal cord taken from in
control group with paraplegia at 48 h after reperfusion
Figure 4
Cross-section of anterior horn spinal cord taken from in
group T3 with neurologically normal at 48 h after reperfusion
Figure 5
Cross-section of anterior horn spinal cord taken from in
group T1 rated Tarlov score 2 at 48 h after reperfusionBMC Neurology 2002, 2 http://www.biomedcentral.com/1471-2377/2/1
Page 5 of 6
(page number not for citation purposes)
groups received treatment of TMP 30 and 60 mg·kg-1 after
reperfusion were significantly better and greater respec-
tively than those in the control group. Animals treated
with 15 mg·kg-1 TMP did not show any neurologic and
histopathologic improvements, indicating a enough dose
of TMP is needed to have therapeutic effect on spinal cord
ischemic injury. These results are not consistent with a re-
cent study [12] examining the protective effects of TMP on
cerebral infarction produced by middle cerebral artery oc-
clusion (MCAO) in rats. Cen et al [12] demonstrated that
TMP 10, 20, 40 mg·kg-1 given intravenously markedly
improved the abnormal nervous symptoms in rats, signif-
icantly reduced the infarct volume at 24 h after MCAO,
and presented a certain dose-response relation. This study
showed that lower dosage of TMP produced inadequate
protective effects against ischemic spinal cord injury. The
differences may be result of different animal species and
model.
Histologic examination confirmed the ability of TMP to
limit neuronal degeneration and necrosis in the anterior
horn motor neurons. Histologic examination of the spinal
cords revealed either no evidence or very little evidence of
injury in TMP-prevented rabbits, whereas spinal cords
from control animals had evidence of extensive spinal
cord injury with central gray matter necrosis, perikaryal
swelling, vacuolization of anterior horn motor neurons,
Nissl substance dissolution, and karyolysis. These mor-
phologic changes developed after ischemia and caused the
physiologic and clinic consequences observed after
ischemic disturbance. The number of normal neurons at
anterior spinal cord has direct relations with neurologic
function, which was manifested by a strong correlation
between the final neurologic outcomes and the number of
normal neurons at anterior spinal cord.
The mechanism of motor neuronal cell death after spinal
cord ischemia and reperfusion has been explored through
molecular, cellular and genic aspects, but it has not been
yet identified. Evidence is gathering that a various of fac-
tors induced over-accumulation of intracellular calcium
triggers proteases, lipase, protein kinase C, nitric oxide
synthase, endonucleases, altered gene transcription, and
release of free radicals, eventually producing neuronal in-
jury and death. The present study did not explore the pro-
tective mechanism of TMP on motor neurons after spinal
cord ischemia. According to pharmacology of TMP and
studies for effects of TMP on cerebral ischemic injury, an-
tiplatelet activation and aggregation, dilating arterioles to
improve microcirculation [17,18], scavenging free radi-
cals, increasing the activity of SOD and decreasing lipid
peroxidation [10], inhibiting calcium overload [9], reduc-
ing the production of nitric oxide and dynorphin A1-13 in
ischemic tissue [19,20], decreasing the protein expression
of c-fos and increasing the protein expression of bcl-2 and
heat shock protein 70(HSP 70) [21,22]may be mecha-
nisms for protection of TMP against spinal cord ischemia
/reperfusion injury. The injection of TMP is a pure extract
from Chinese herbs, and has the properties of abundant
resources, cheapness, wide range of dose in clinic and few
side effects. Thus we anticipate that TMP might have im-
portant clinical application as a treatment in the preven-
tion of spinal cord injury during thoracoabdominal aortic
operations.
Conclusion
It can be concluded from these experiments that tetrame-
thylpyrazine (TMP), an intravenous drug made from tra-
ditional Chinese herbs, significantly improves the
neurologic injury secondary to spinal cord ischemia and
reperfusion after aortic occlusion for 20 minutes in the
rabbit.
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